36th EDRN Steering Committee Meeting - Wednesday 28 October Agenda

Agenda for Wednesday, October 28th, for the 36th EDRN Steering Committee Meeting

12:00 p.m. - 3:00 p.m. (all times Eastern Daylight Time)

Session 4 - Study Designs for Clinical Utility Trials

  • Ziding Feng, Ph.D., Fred Hutchinson Cancer Research Center
  • Steve Skates, Ph.D., Massachusetts General Hospital/Harvard
NCI Program Directors:
  • Paul Wagner, Ph.D.
  • Guillermo Marquez, Ph.D.
Note Takers:
  • Ziding Feng and Paul Wagner
12:00 p.m. - 12:20 p.m. EDT

16-Stage Shift in Ovarian Cancer Early Detection Trials in High-Risk Women
Steve Skates, Ph.D., Massachusetts General Hospital/Harvard

12:20 p.m. - 12:40 p.m. EDT

Presentation Discussion

12:40 p.m. - 1:00 p.m. EDT

17-Randomized Clinical Trial of Serum Biomarkers versus Ultrasound for Early Detection of Hepatocellular Carcinoma
Amit Singal, M.D., The University of Texas Southwestern Medical Center

1:00 p.m. - 1:20 p.m. EDT

Presentation Discussion

1:20 p.m. - 1:40 p.m. EDT

18-Clinical Utility of Biomarker Driven Management of Indeterminate Pulmonary Nodules
Pierre Massion, M.D., Vanderbilt-Ingram Cancer Center/Vanderbilt University Medical Center

1:40 p.m. - 2:00 p.m. EDT

Presentation Discussion

2:00 p.m. - 2:20 p.m. EDT

19-Clinical utility trial incorporating biomarkers into risk models for lung cancer screening
Samir Hanash, M.D., Ph.D., The University of Texas MD Anderson Cancer Center

2:20 p.m. - 2:40 p.m. EDT

Presentation Discussion

2:40 p.m. - 3:00 p.m. EDT

Future Directions

3:00 p.m. EDT


Version 5.1.0